BHALLA NARINDER PAL (Chief Medical Officer) received a stock award from LEXEO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2026ACC: 0002109299-26-000004
Officer· Chief Medical Officer
Since Feb 2026
+346.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
346.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+49.50K
Price / share
—
Trade value
—
% of position
New position
2/13/2026
0.00→49.50K
Total
Net shares
+49.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | A · Award | +49.50K | — | — | New position | 0.00 | 49.50K |
| Total | +49.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
297K shares
Shares
+297K
Strike price
6.31
Held after
297K
Exercisable
—
2/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock297K shares | 2/13/2026 | A · Award | +297K | 6.31 | — | 297K |